News

File

News

05/25/2022 PDF Notice to the Market - Declaration of Disposal of Relevant Equity Interest* (323 Kb)
05/16/2022 PDF 1Q22 Presentation of Results (4237 Kb)
05/12/2022 PDF 1Q22 Earnings Release (2083 Kb)
05/10/2022 PDF Notice to the Market - Declaration of Acquisition of Relevant Shareholding* (485 Kb)
04/28/2022 PDF Ordinary and Extraordinary Shareholders´ Meeting Held on April 18, 2022* (237 Kb)
04/28/2022 PDF Voting Analytical Map, referring to the Ordinary and Extraordinary General Meeting of 04/18* (820 Kb)
04/27/2022 PDF Notice to Shareholders - Distribution of Mandatory and Additional Dividends* (601 Kb)
04/27/2022 PDF Summary of Decisions: Ordinary and Extraordinary Shareholders´ Meeting Held on April 18, 2022* (163 Kb)
04/18/2022 PDF Final Synthetic Voting Map, referring to the Ordinary and Extraordinary General Meeting of 04/18* (453 Kb)
04/18/2022 PDF Summary of Decisions on the Election of the Investor Relations Officer held on April 18, 2022* (244 Kb)
04/16/2022 PDF Consolidated Voting Map, referring to the Ordinary and Extraordinary General Meeting of 04/18* (86 Kb)
04/16/2022 PDF Notice to the Market - Re-presentation of the Consolidated Distance Voting Map (D-1)* (189 Kb)
04/08/2022 PDF Management´s Proposal for the Ordinary and Extraordinary General Meeting to be held on March 18, 2022* (2978 Kb)
04/05/2022 PDF Notice to Shareholders - Precautionary Guidelines for OEGA 2022* (525 Kb)
04/04/2022 PDF Notice to Shareholders - Waiver of Signature and Authentication for OEGA 2022* (518 Kb)
03/25/2022 PDF Call Notice: Ordinary and Extraordinary General Meeting to be held on April 18, 2022* (77 Kb)
03/25/2022 PDF Notice to the Market - 2Q22 Ferrochrome Regular Supply Price in Europe (615 Kb)
03/23/2022 PDF Notice to Shareholders - FERBASA Legal Publications* (594 Kb)
03/18/2022 PDF 2022 Public Meeting Presentation - 4Q21 Results (13489 Kb)
03/08/2022 PDF Notice to the Market - Nomination to the Board of Directors and Fiscal Council AGO 2022 by minority shareholder* (504 Kb)
03/04/2022 PDF 2021 Management Report (1963 Kb)
03/04/2022 PDF Management Report 2021 (1593 Kb)
01/14/2022 PDF Notice to Shareholders - Annual General Meetings (226 Kb)
01/12/2022 PDF Notice to the Market - Clarifications about the article published by Valor Econômico newspaper* (305 Kb)

1 - copy

CIA DE FERRO LIGAS DA BAHIA - FERBASA
SOCIEDADE ANÔNIMA ABERTA
CNPJ 15.141.799/0001-03
NIRE 293.000.043.91

OGM/EGM 2021 Participation - Preventive Guidelines on COVID 19

CIA. DE FERRO LIGAS DA BAHIA - FERBASA S.A. (B3: FESA3 / FESA4) ("FERBASA" or "Company"), herby informs that, due to the current situation related to COVID-19 and the proximity of the Ordinary and Extraordinary General Meeting - OGM/EGM, that which will take place on April 20, 2021, at 10:00 am (Brasília time), at the Company‘s headquarters, Estrada de Santiago, s/nº, Pojuca, BA, there will be protective and preventive measures to access to the company‘s facilities. For this purpose, participants will be required to observe some preventive procedures that are part of the Company‘s Medical and Health Protocols, namely: (i) mandatory use of a protective mask, available in the occasion, at all times inside Ferbasa’s facilities; (ii) the minimum distance of 1.5 meters between people must be observed in all facilities of the Company; (iii) all visitors must undergo a symptom screening and clinical analysis carried out by Ferbasa‘s Medical Service; (iv) shareholders and / or their legal representatives who have had flu-like symptoms in the last 14 days will be unable to enter Ferbasa‘s premises; (v) depending on the clinical evaluation, the Ferbasa Medical Service may request the participant to perform the rapid test for IgG and IgM antibodies, assessing the contagion of COVID-19 - the test will be carried out at the Ferbasa Medical Center. It is important to note that, if an active case of COVID-19 is detected, the shareholder and / or his legal representative will not be able to enter the Company‘s facilities, being unable to participate in person at the Ordinary and Extraordinary General Meeting; (vii) the participant will be asked to perform hand hygiene before joining the Company and whenever using any object that is not part of his or her personal belongings, using, for this purpose, alcohol gel available in dispensers or washing hands with water and soap; (viii) all participants will be instructed to respect the respiratory etiquette in all company facilities, according to the widely publicized Health Protocol.

The Company reiterates its commitment to the best corporate governance practices and the compliance with all measures to prevent, control and mitigate the transmission risks of COVID-19 in any and all facilities of the Company, strictly following the general guidelines of the Ordinance Joint No. 20, of June 18, 2020, as well as the restrictions and guidelines determined by the State and Municipal Decrees in force.

Salvador, April 06, 2021

Heron Albergaria de Melo
CFO & IRO